Sentir

CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4)

Centers for Disease Control and Prevention · K243274

FDA-authorized Predetermined Change Control Plan

1 of 64 Non-AI1 of 35 in Microbiologyauthorized 2025
Company
Centers for Disease Control and Prevention
510(k)/De Novo #
K243274
Decision date
2025-07-11
Panel
Microbiology
Pathway
510(k)
Category
Non-AI
PCCP type
I/O expansion
Monitoring commitment
Not stated

What this PCCP covers. Permits input/output expansion to compatible devices

Browse

Other PCCPs from Centers for Disease Control and Prevention

Other Microbiology PCCPs

Want the monitoring teardown?

We read the PCCP for CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel: Influenza A/B Typing Kit (VER 2); Influenza A SubTyping Kit (VER 4); Influenza B Genotyping Kit (VER 1.1 and 2); and Influenza A/H5 Subtyping Kit (VER 4), then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.

Book a call

Source: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.

This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.